August 2008
HIV-1 Specific Cell Entry Inhibitor Structure
With the registration of the first oral Entry Inhibitor, Maraviroc (Celsentry) treatment strategies may change in the coming years. For this reason Virology Education is organizing the following course:
How to use CCR5 antagonists in clinical practice
Seven countries
These courses will be held in in seven different European countries attended by participants from fifteen different countries. The official language will be English. We have applied for CME accreditation. This program is made possible with an unristricted educational grant by Pfizer.
Countries & Dates
-
Finland, Sweden, Norway and Denmark, 3 September
-
UK & Ireland, 4 September
-
Italy, 6 October
-
Germany, Austria & Switzerland, 7 October
-
The Netherlands, Belgium & Luxembourg, 17 December
-
France, 18 December
-
Spain, 19 December
The program -
CCR5 clinical trial data
-
Tropism and tropism testing
-
Resistance among NRTI, NNRTI, PI, and Integrase inhibitors
-
Drug-drug interactions with CCR5 inhibitors
-
Presentation of clinical cases
More Information?
If you would like to have more information on these courses please contact Marjon van der Kaa, Event Manager Virology Education. marjon.vanderkaa@vironet.com
